
Investor Relations Captor Therapeutics ®
Prezentacje
-
-
Investor FactSheet Q3 2022
-
ESMO Asia Congress, Singapore -poster
-
ENA 2022, Barcelona - poster
-
5th Annual Targeted Protein Degradation Summit, Boston - poster
-
Corporate Presentation H1/2022
-
R&D Day
-
Investor Factsheet Q1 2022
-
Investor Day Presentation
-
CT-01 molecular target disclosure – what does this mean for project development?
-
2nd Annual Targeted Protein Degradation Europe Summit
-
Kamienie milowe w projektach CT-01 i CT-03 - co to oznacza dla Spółki i inwestorów?
-